Back
Corcept Therapeutics Stock Price Chart
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Buy
62
CORT
Corcept Therapeutics
Last Price:
24.50
Seasonality Move:
4.21%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight selling pressure.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.27 | Buy |
| 20-day SMA: | 23.48 | Buy |
| 50-day SMA: | 23.89 | Buy |
| 200-day SMA: | 26.59 | Sell |
| 8-day EMA: | 23.62 | Buy |
| 20-day EMA: | 23.57 | Buy |
| 50-day EMA: | 23.87 | Buy |
| 200-day EMA: | 25.04 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 60.59 | Buy |
| Chaikin Money Flow: | -24445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.75 - 24.99) | Buy |
| Bollinger Bands (100): | (21.9 - 27.52) | Buy |
Corcept Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 25.08 while CORT 8-day simple moving average is 23.27, which is a Buy signal.
- The stock price of CORT is 25.08 while Corcept Therapeutics 20-day SMA is 23.48, which makes it a Buy.
- Corcept Therapeutics 50-day simple moving average is 23.89 while CORT share price is 25.08, making it a Buy technically.
- CORT stock price is 25.08 and Corcept Therapeutics 200-day simple moving average is 26.59, creating a Sell signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a Buy
The current Corcept Therapeutics [CORT] share price is $25.08. The Score for CORT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
2.6B
Price in USD:
25.08
Share Volume:
2.11M
Corcept Therapeutics 52-Week Range
52-Week High:
34.28
52-Week Low:
20.84
Buy
62
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?
The Corcept Therapeutics stock price is 25.08 USD today. -
Will CORT stock go up or go down?
Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Corcept Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
- Corcept Therapeutics share price is 25.08 while CORT 8-day exponential moving average is 23.62, which is a Buy signal.
- The stock price of CORT is 25.08 while Corcept Therapeutics 20-day EMA is 23.57, which makes it a Buy.
- Corcept Therapeutics 50-day exponential moving average is 23.87 while CORT share price is 25.08, making it a Buy technically.
- CORT stock price is 25.08 and Corcept Therapeutics 200-day simple moving average is 25.04, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.11 per share, an increase this year of $0.03 per share, and an increase next year of $0.33 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
- CORT Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Corcept Therapeutics is a Sell
- Corcept Therapeutics Relative Strength Index (RSI) is 60.59, which suggest Corcept Therapeutics is overbought
- The Bollinger Bands (25) for Corcept Therapeutics is (22.75 - 24.99), which suggest Corcept Therapeutics is a Buy
- The Bollinger Bands (100) for Corcept Therapeutics is (21.9 - 27.52), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.